中国科学院机构知识库网格系统: 检索

浏览/检索结果: 共7条，第1-7条

帮助

条数/页：排序方式：
	Acid-activatible micelleplex delivering siRNA-PD-L1 for improved cancer immunotherapy of CDK4/6 inhibition 期刊论文 OAI收割 CHINESE CHEMICAL LETTERS, 2021, 卷号: 32, 期号: 6, 页码: 1929-1936 作者: Gao, Jing; Zhang, Hanwu; Zhou, Fengqi; Hou, Bo; Chen, Meiwan \| 收藏 \| 浏览/下载：65/0 \| 提交时间：2021/08/17 Cancer immunotherapy siRNA delivery Acid-activatible micelleplex CDK4 6 inhibitor PD-L1 knockdown
	Arsenic trioxide (ATO) induced degradation of Cyclin D1 sensitized PD-1/PD-L1 checkpoint inhibitor in oral and esophageal squamous cell carcinoma 期刊论文 OAI收割 JOURNAL OF CANCER, 2020, 卷号: 11 作者: Zhu, Guanxia; Li, Xia; Li, Jiong; Zhou, Wei; Chen, Zhongjian \| 收藏 \| 浏览/下载：45/0 \| 提交时间：2020/11/30 esophageal squamous cell carcinoma oral squamous cell carcinoma arsenic trioxide cyclin D1 PD-L1 CDK4/6
	Preclinical characterization of SHR6390, a novel CDK 4/6 inhibitor, invitro and in human tumor xenograft models 期刊论文 OAI收割 CANCER SCIENCE, 2019, 卷号: 110, 期号: 4, 页码: 1420-1430 作者: Long, Fei; He, Ye; Fu, Haoyu; Li, Yun; Bao, Xubin \| 收藏 \| 浏览/下载：45/0 \| 提交时间：2020/07/01 breast cancer CDK 4/6 drug resistance palbociclib SHR6390
	Simultaneous inhibition of PI3K alpha and CDK4/6 synergistically suppresses KRAS-mutated non-small cell lung cancer 期刊论文 OAI收割 CANCER BIOLOGY & MEDICINE, 2019, 卷号: 16, 期号: 1, 页码: 66-+ 作者: Wang, Yuxiang; Li, Xian; Liu, Xueling; Chen, Yi; Yang, Chunhao \| 收藏 \| 浏览/下载：34/0 \| 提交时间：2020/07/01 PI3K alpha CDK4/6 KRAS NSCLC CYH33
	Simultaneous inhibition of PI3Kα and CDK4/6 synergistically suppresses KRAS-mutated non-small cell lung cancer 期刊论文 OAI收割 CANCER BIOLOGY & MEDICINE, 2019, 卷号: 16, 期号: 1, 页码: 66-83 作者: Wang, Yuxiang; Li, Xian; Liu, Xueling; Chen, Yi; Yang, Chunhao \| 收藏 \| 浏览/下载：23/0 \| 提交时间：2024/03/21 PI3K alpha CDK4/6 KRAS NSCLC CYH33
	Simultaneous inhibition of PI3Kα and CDK4/6 synergistically suppresses KRAS-mutated non-small cell lung cancer 期刊论文 OAI收割 Cancer Biology and Medicine, 2019, 卷号: 16, 期号: 1, 页码: 66 作者: Wang Yuxiang; Li Xian; Liu Xueling; Chen Yi; Yang Chunhao \| 收藏 \| 浏览/下载：41/0 \| 提交时间：2020/12/24 PI3Kα CDK4/6 KRAS NSCLC CYH33
	Design, synthesis and biological evaluation of tetrahydronaphthyridine derivatives as bioavailable CDK4/6 inhibitors for cancer therapy 期刊论文 OAI收割 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 卷号: 148, 页码: 140-153 作者: Zha, Chuantao; Deng, Wenjia; Fu, Yan; Tang, Shuai; Lan, Xiaojing \| 收藏 \| 浏览/下载：83/0 \| 提交时间：2019/01/08 Structure-based drug design Selective CDK4/6 inhibitors Structure-activity relationship study In vivo antitumor activity